Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting…
Bridgeline Announces Financial Results for the Fourth Quarter of Fiscal 2024
WOBURN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ:…
Immutable Holdings Announces Voting Results for Its Annual General Meeting of Shareholders
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Immutable Holdings Inc. (NEO:HOLD) (“Immutable…
Immutable Holdings Announces Voting Results for Its Annual General Meeting of Shareholders
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Immutable Holdings Inc. (NEO:HOLD) (“Immutable…
Press Release: Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing
Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update…
Euro NCAP Releases final 2024 Commercial Van Results
Today, Euro NCAP announces the latest safety results for commercial vans, highlighting…
Euro NCAP Releases final 2024 Commercial Van Results
Today, Euro NCAP announces the latest safety results for commercial vans, highlighting…
Euro NCAP Releases final 2024 Commercial Van Results
Today, Euro NCAP announces the latest safety results for commercial vans, highlighting…
Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posts Strong Adjusted EBITDA Margin1 for Fiscal Year 2024 and Returns to…